
Matt Dean
Articles
-
1 week ago |
cellandgene.com | Erin Harris |Todd Andrews |James Calle |Matt Dean
Webinar: Advanced Contamination Control for Cell Therapy: Automation, Assays, and Process EfficiencyThis webinar explores contamination control in cell therapy manufacturing, focusing on automated closed systems, larger bioprocess containers, and rapid analytical assays. It highlights how these tools enhance sterility, efficiency, and product quality. Experts Alexandra Lisi and Sandi True will share insights into integrating these solutions for improved operational effectiveness.
-
Jan 17, 2025 |
peoplemanagement.co.uk | Matt Dean
The summary reports of the recent tribunal judgment in Rustambekov v Fieldfisher LLP have been that a senior associate was unfairly dismissed after being falsely accused of sexual assault by a female colleague. As ever, there’s more to it than that. The case raises important issues that will be current for some years – particularly as the new legal duty to take all reasonable steps to eradicate sexual harassment beds down. Undoubtedly, fear surrounds the new duty.
-
Oct 10, 2024 |
frontiersman.com | Matt Dean
In the vice-presidential debate, U.S. Sen. JD Vance (R-OH) signaled a major change in Republican health care policy; but if you weren’t looking for it, you might have missed it. After years of Republicans promoting a centralized system that pays for prescription drugs and services through Politburo-approved benefit sets, the Republican vice-presidential nominee signaled a surprising shift towards federalism when he proposed that states ought to become the laboratories of health care policy.
-
Oct 10, 2024 |
heartland.org | Matt Dean
Insurance firms, drug developers, and health care companies are all using AI thanks to unprecedented new investment in the groundbreaking technology. Meanwhile, the federal government has begun regulating how AI should “decide” who gets care, who doesn’t, and how it should be delivered. States have an interest in being cautious of both.
-
Oct 7, 2024 |
thecentersquare.com | Matt Dean
In the vice-presidential debate, U.S. Sen. JD Vance (R-OH) signaled a major change in Republican health care policy; but if you weren’t looking for it, you might have missed it. After years of Republicans promoting a centralized system that pays for prescription drugs and services through Politburo-approved benefit sets, the Republican vice-presidential nominee signaled a surprising shift towards federalism when he proposed that states ought to become the laboratories of health care policy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →